tiprankstipranks
Soros Fund buys Horizon Therapeutics, exits BNY Mellon in Q4
The Fly

Soros Fund buys Horizon Therapeutics, exits BNY Mellon in Q4

George Soros’ Soros Fund Management disclosed in an SEC filing its holdings as of December 31, 2022. The fund’s 27 new buys during the fourth quarter included, by size of position, Horizon Therapeutics (HZNP), iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD), First Horizon (FHN), Altra Industrial Motion (AIMC), and Signify Health (SGFY). Soros exited 130 positions during the quarter, including by size of previous position Agree Realty (ADC), Bank of New York Mellon (BK), Las Vegas Sands (LVS), Sarepta (SRPT), and Analog Devices (ADI). The fund increased its stake in 18 holdings, including by size of previous position Alphabet Class A (GOOGL), Cboe Global Markets (CBOE), Invesco QQQ Trust Series 1 (QQQ), Booking (BKNG), and TransDigm (TDG). Soros reduced its stake in 27 holdings, including by size of previous position Rivian (RIVN), Amazon (AMZN), DR Horton (DHI), T-Mobile (TMUS), and Nike (NKE). The fund’s top holdings as of December 31, in order of size, were Horizon Therapeutics, Rivian, iShares iBoxx $ Investment Grade Corporate Bond ETF, First Horizon, and Alphabet Class A.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on HZNP:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles